000			04911nam a22003735i 4500
001			81654
003			ES-MaUEC
005			20230207040340.0
007			cr nn 008mamaa
008			150622s2015 ne | s |||| 0|eng d
020			_a9789400776968
024	7		_a10.1007/978-94-007-7696-8 _2doi
050		4	_aR853.B54 _bG464 2015
245	1	0	_aGeneral Methods in Biomarker Research and their Applications _cedited by Victor R. Preedy, Vinood B. Patel.
260			_aDordrecht, Netherlands _bSpringer _c2015
300			_a1 recurso en línea (204 ilustraciones, 130 ilustraciones en color eReference.
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aBiomarkers in Disease: Methods, Discoveries and Applications _x2451-9766
505	0		_aBiomarker for Amyotrophic Lateral Sclerosis (Motor Neurone Disease) -- Biomarkers and their applications to toxicology and toxicogenomics -- Biomarkers for Depression -- Biomarkers in Chronic Obstructive Pulmonary Disease (COPD): Current Concerns and Future Prospects -- Biomarkers in Urine and Use of Creatinine -- Biomarkers of Graft-Versus-Host Disease -- Biomarkers of Menopause -- Biomarkers of Parkinson's Disease -- Biomarkers of Vector Bites -- Biomarkers of the menopause.-Â{u3A32}ronic Heart Failure and Serum Collagen -- FABP3 as biomarkers -- Fetal Membrane Biomarkers.-Â{u6B2F}ow Cytometry as Platform for Biomarker Evaluation -- Formalin-fixed paraffin-embedded tissue (FFPET) sections for biomarker discovery -- Glycomics as biomarkers -- Inflammasome Proteins as Biomarkers of Injury and Disease -- Isoprostanes as biomarkers of disease and early biological effect.-Mass spectrometry for biomarker discovery -- Micro RNA as Biomarker for Brain Injury -- MIP-1alpha as biomarker -- Natriuretic Peptides for Diagnosis, Prognosis and Management of Heart Failure -- OMICS-based approaches to biomarker discovery and challenges of subsequent validation -- Pediatric biomarkers after cardac surgery -- Pentraxin 3 as Biomarker -- Pfetin: Novel prognostic biomarker -- Plasma galectin-3 as biomarker -- S100B as a Biomarker -- Salivary amylase as a stress biomarker -- Seasonal allergic rhinitis and systems biology-oriented biomarker discovery -- Serum Heat Shock Proteins as Novel Biomarker for Heart Failure -- Urinary Biomarkers of Environmental Health: Jet Fuel -- YKL-40 as Biomarker: Focus on Cardiovascular Disease.
520	3		_aIn the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics and so on. The chapters are written by national or international experts and specialists.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988			_aEBOOK, asignarmaterias, EBSPRINGER,
650	2	7	_aFarmacología _2embne _9137893
650		7	_aFarmacología _2embne _9137893
700	1		_aPreedy, Victor R _eeditor literario _985990 _0Local
700	1		_aPatel, Vinood B _eeditor literario _985991 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-007-7696-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12902445 _b10-10-17 _c18-01-16
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gne _h0
945			_aR853.B54 G464 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11572061 _z06-04-17
999			_c81654 _d81654 _x1